Several breast cancer cell lines are currently used to study triple negative tumours; we took advantage of MDA-MB-468 which has been identified as ER-, PR- and HER- basal breast cancer cell, as approximately the 80% of TNBC [29]. This evidence concerns the gene ESR1 and breast carcinoma.